Fig. 4From: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyTime-to-first exacerbation following FF/UMEC/VI initiation. FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, CI confidence intervalBack to article page